Mounjaro KwikPen 2.5mg is a long-acting dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. The primary active constituent, Tirzepatide, functions as a physiological glycemic regulator and appetite suppressant by enhancing insulin secretion, increasing insulin sensitivity, and delaying gastric emptying.

Dosage & Administration

• Dosage: Adhere strictly to the dosing schedule and administration instructions provided by your physician.
• Method: Subcutaneous injection into the abdomen, thigh, or upper arm.
• Site Rotation: Alternate injection sites weekly to maintain skin integrity.
• Cycle: One KwikPen contains 4 fixed doses (one month supply).
• Missed Dose Protocol: Administer a missed dose within 4 days of the scheduled date. If more than 4 days have elapsed, the missed dose should be omitted. It should be resumed on their usual schedule day. The interval between two consecutive doses must not be less than 72 hours.

Technical Specification

• Product Form: Multi-dose pre-filled KwikPen.
• Active Ingredient: Tirzepatide
• Concentration: 2.5mg Tirzepatide per dose.

Ingredient Functionality

• Tirzepatide: A 39-amino acid modified peptide that bi-mimetically activates both GIP and GLP-1 receptors.
• Glycemic Control: Enhances first- and second-phase insulin secretion and reduces glucagon levels in a glucose-dependent manner.
• Metabolic Support: Increases energy expenditure and delays gastric emptying, leading to a sustained reduction in caloric intake.
• GIP Receptor Agonism: Complements GLP-1 action to improve lipid metabolism and further reduce postprandial glucose excursions.

Safety & Storage

• Temperature Control: Maintain refrigeration between 2°C and 8°C. Do not subject to freezing temperatures.
• Ambient Storage: The KwikPen remains stable at room temperature (up to 25°C) for a maximum of 21 days.
• Device Disposal: The pen must be discarded 28 days after the first dose is administered.
• Visual Inspection: Solution must be clear and colorless to slightly yellow; discard if particles or cloudiness are present.
• Compatible needles are required for administration; not included in this package.
  
  Mounjaro 15 mg
  Mounjaro 7.5 mg